Encycle Therapeutics Analysis: $10M Raised
What is Encycle Therapeutics?
Biotech company developing drug-like nacellins
Location
Toronto, Canada
Employees
1-10
Founded
2012
Product Features & Capabilities
- Nacellins targeting integrin alpha-4-beta-7
- Drug-like macrocycles for intracellular interactions
- Screening library of cell-permeable nacellins
Use Cases
Develop orally bioavailable inhibitors for IBD; Target SMURF2 for fibrosis treatment; Collaborate with pharmaceutical companies for nacellin screening; Create alternatives to monoclonal antibodies; Explore drug-like properties of nacellins
Other Considerations
Acquired by Zealand Pharma; Collaborated with multiple pharmaceutical companies; Raised funding from Takeda Ventures
See something that needs updating? Suggest edits to this profile.